Clinical Trials Directory

Trials / Completed

CompletedNCT04988919

Consumption of 4D Dietary Supplement on Perceptual-Cognitive and Visual-Motor Performance

Acute Consumption of 4D Dietary Supplement vs. Placebo: Effects on Perceptual-Cognitive and Visual-Motor Performance

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
University of Central Florida · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of this investigation is to determine if supplementation with the 4D dietary supplement impacts perceptual-cognitive and visual-motor skills in healthy individuals.

Detailed description

Multi-ingredient supplements (MIS) have been reported to positively impact various aspects of performance. While caffeine alone has been shown to improve aerobic performance, resistance training (such as bench press), reaction time and sprint performance, it has also been suggested that it lacks the ability to improve cognition. Therefore, the purpose of this investigation is to examine the effects of a caffeine containing MIS on measures of cognition and reaction time, with the intent of providing additional benefits to athletic performance. This study will utilize a randomized, double-blind, placebo-controlled design. Following two familiarization trials, participants will complete two testing visits. During these visits, they will complete baseline assessments, consume either the 4D dietary supplement or a taste matched placebo, and rest for 45 minutes. Reaction time, cognition assessments (visual tracking speed), and reactive agility performance will be assessed following the rest period.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT4Dmulti-ingredient supplement mixed with 24 ounces of water
DIETARY_SUPPLEMENTplacebotaste-matched placebo mixed with 24 ounces of water

Timeline

Start date
2021-07-26
Primary completion
2021-10-04
Completion
2021-10-04
First posted
2021-08-04
Last updated
2021-10-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04988919. Inclusion in this directory is not an endorsement.